Zhao Li

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Cardiovascular Disease

Glycemic Control

Endothelial Cells

Top Venues

Journal of basic and clinical physiology and pharmacology

Pharmacological reports : PR

This page only lists publications with an associated author ORCID identifier.

Publications

Francesca Amici, Christian Ciarlo, Jenine Abumusallam, Madeline Kravitz, Angel-Rose Weber, Hanna Meister, Zhao Li
Protecting cardiomyocytes from hypoxia-reoxygenation injury, empaglifozin and liraglutide alone or in combination? Journal of basic and clinical physiology and pharmacology 35 (1-2) (2024)
Francesca Amici, Christian Ciarlo, Jenine Abumusallam, Madeline Kravitz, Angel-Rose Weber, Hanna Meister, Zhao Li
Protecting cardiomyocytes from hypoxia-reoxygenation injury, empaglifozin and liraglutide alone or in combination? Journal of basic and clinical physiology and pharmacology 35 (1-2) (2024)
Francesca Amici, Christian Ciarlo, Jenine Abumusallam, Madeline Kravitz, Angel-Rose Weber, Hanna Meister, Zhao Li
Protecting cardiomyocytes from hypoxia-reoxygenation injury, empaglifozin and liraglutide alone or in combination? Journal of basic and clinical physiology and pharmacology 35 (1-2) (2024)
Francesca Amici, Christian Ciarlo, Jenine Abumusallam, Madeline Kravitz, Angel-Rose Weber, Hanna Meister, Zhao Li
Protecting cardiomyocytes from hypoxia-reoxygenation injury, empaglifozin and liraglutide alone or in combination? Journal of basic and clinical physiology and pharmacology (2024)
Jennifer Cessario, Vanessa Pierre-Louis, Jenny Wahl, Zhao Li
Empagliflozin, alone or in combination with liraglutide, limits cell death in vitro: role of oxidative stress and nitric oxide. Pharmacological reports : PR 73 (3) (2021)